Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2075 of 5804
-
Doctors create new tool to predict surgery difficulty for rare tumors
Knowledge-focused CompletedThis study aims to develop and preliminarily validate an anatomy-morphological risk grading system (IUPU-PPGL Grading) based on preoperative imaging 3D reconstruction, in order to quantitatively assess surgical complexity and perioperative safety in PPGL patients, and to evaluate…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can a zap in the ear silence the ringing? new trial aims to find out
Symptom relief Recruiting nowTinnitus, or ringing in the ears, affects 10% to 30% of the population. Of those, 20% have tinnitus bothersome enough to seek medical attention. In many people, tinnitus can significantly affect the quality of life. At this point in time, there is no effective treatment or cure a…
Phase: NA • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New combo therapy offers hope for stroke Survivors' shoulder pain
Symptom relief CompletedHemiplegic shoulder pain (HSP) affects up to 60% of moderate to severely impaired stroke survivors. HSP is associated with poor rehabilitation outcomes, including interference with activities of daily living (ADLs) and poor quality of life (QoL). While many treatments for HSP hav…
Phase: NA • Sponsor: MetroHealth Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Heart attack procedure under review: does PCI save more lives?
Disease control OngoingResearch Objectives: This clinical trial aims to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI). The primary objective is to determine whether this approach can reduce the incidence of major adverse cardio…
Phase: NA • Sponsor: Kaiyang Lin • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New cocktail of drugs shows promise for tough prostate cancer
Disease control CompletedThis is a multi-center, Phase I study of apalutamide in combination with abiraterone acetate, docetaxel and prednisone in patients with metastatic mastrate resistant prostate cancer (mCRPC). This study is designed to determine the dose that apalutamide can be administered safely…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New urine test could spare bladder cancer patients from painful scopes
Diagnosis Recruiting nowVoided urinary cytology (VUC) is the most widely used urine-based assay for detecting bladder cancer (BCa); however, it fails to detect approximately 50% of low-grade or early stage BCa when it is most curable. Furthermore, the detection rate of VUC for recurrent BCa is not much …
Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Prostate cancer drug enzalutamide tested for Long-Term safety in ongoing study
Disease control Recruiting nowThe purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) whic…
Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Virtual Check-Ups after ER visits could help kids with asthma breathe easier
Disease control CompletedIn the US, children from minority ethnic and racial backgrounds suffer disproportionately from asthma and account for substantially more emergency department (ED) visits and hospitalizations than non-minority children. While NHLBI guidelines recommend daily preventive medications…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis is a safety, efficacy, and pharmacokinetics (PK) study of vibostolimab (MK-7684) as monotherapy and in combination with pembrolizumab (MK-3475) or pembrolizumab plus pemetrexed and carboplatin in adults with metastatic solid tumors for which there is no available therapy tha…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Massive study aims to unlock secrets of rare inflammatory diseases
Knowledge-focused Recruiting nowBackground: Some diseases cause chronic inflammation with intermittent flares in the body. These are called autoinflammatory diseases. They can cause fevers, rashes, ulcers, and other problems. Researchers want to learn more about the causes and effects of these diseases. They h…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New hope for metastatic breast cancer: pill combo may replace chemo
Disease control OngoingThis is an open-label, pilot study designed to evaluate the safety and feasibility of combining anastrozole and palbociclib in the following two cohorts: Cohort A) as first-line therapy and Cohort B) as maintenance therapy after first-line chemotherapy in postmenopausal patients …
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Immunotherapy combo shows promise for rare cancers, but study halted early
Disease control TerminatedThis is an investigator initiated single institution, open-label study to evaluate the antitumor activity, safety, and tolerability of durvalumab in combination with tremelimumab in subjects with select advanced rare solid tumors.
Phase: PHASE2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Heart drug metoprolol may shield patients from Post-Surgery heart injury
Disease control CompletedThe purpose of this research study is to test if a commonly used, FDA-approved medication, called metoprolol, given at the conclusion of anesthesia following surgery, and during postoperative admission, reduces the possibility of heart related complications in patients with coron…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Oxygen therapy shows promise for aging brains and bodies
Disease control CompletedRecent studies show preliminary evidence of HBOT therapeutic effects on angiogenesis, increased tissue blood flow and oxygenation correlated with tissue function. Our primary hypothesis is that HBOT will have beneficial effects on the above mentioned organs associated with aging…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Genetic test could shorten hospital stays for fungal infection patients
Knowledge-focused TerminatedMonocentric study with the objective to evaluate the impact of genotyping CYP2C19 on the hospitalization period. The genotyping will permit to adapt at best the Voriconazole posology.
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists hunt for clues in body fluids to predict liver failure outcomes
Knowledge-focused OngoingAcute liver injury (ALI) and acute liver failure (ALF) are rare clinical conditions, the latter often associated with a poor outcome. To improve outcomes for these patients, clinicians need to develop a clearer understanding of the pathophysiology of this condition. Biomarkers an…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New balloon treatment shows promise for leg artery blockages
Disease control CompletedThis clinical study is a prospective, non-randomized, multicenter study to demonstrate the acceptable safety and performance of angioplasty with the Ranger DCB in native femoropopliteal artery lesions. It is intended that all patients with qualifying lesions would be considered f…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can exercise coaching keep seniors safe from falls?
Prevention CompletedThe investigators propose a 36-month multi-center randomized effectiveness trial to compare the impact of an Enhanced Usual Care (Control) intervention, with Exercise Coaching (Exercise), on Serious Fall-Related Injuries (SFI) in patients with a previous fragility fracture (FF). …
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Massive gene hunt launched to unlock Alzheimer's secrets
Knowledge-focused Recruiting nowThe goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history o…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Daily ultrasound could keep heart failure patients out of the hospital
Disease control CompletedOur hypothesis: a daily bedside echocardiographic assessment, protocolized, simple and reproducible estimation of filling pressures with an evaluation of mitral inflow and the inferior vena cava, allow a more reliable estimate of the true blood volume of the patient and thus lead…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC